Clinical Trial: Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen: A Randomized Clinical Trial in Iraq.

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07145827) titled 'Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen: A Randomized Clinical Trial in Iraq.' on Aug. 18.

Brief Summary: The goal of this clinical trial is to learn if metformin can reduce the increase in endometrial thickness caused by tamoxifen in women with estrogen-positive breast cancer taking tamoxifen for more than 1 year. It will also learn about the safety of taking metformin with tamoxifen. The main questions it aims to answer are:

1. Does metformin decrease endometrial thickness in women receiving tamoxifen?

2. What medical problems do participants have when taking metf...